West Pharmaceutical Services Long-Term Investments 2010-2024 | WST

West Pharmaceutical Services long-term investments from 2010 to 2024. Long-term investments can be defined as the aggregate value of debt and or equity investments with maturities or benefits lasting more than one year.
  • West Pharmaceutical Services long-term investments for the quarter ending September 30, 2024 were $0.218B, a 11.31% increase year-over-year.
  • West Pharmaceutical Services long-term investments for 2023 were $0.21B, a 2.49% increase from 2022.
  • West Pharmaceutical Services long-term investments for 2022 were $0.205B, a 1.35% decline from 2021.
  • West Pharmaceutical Services long-term investments for 2021 were $0.208B, a 3.26% decline from 2020.
West Pharmaceutical Services Annual Long-Term Investments
(Millions of US $)
2023 $210
2022 $205
2021 $208
2020 $215
2019 $193
2018 $91
2017 $86
2016 $83
2015 $61
2014 $61
2013 $61
2012 $60
2011 $56
2010 $48
2009 $38
West Pharmaceutical Services Quarterly Long-Term Investments
(Millions of US $)
2024-09-30 $218
2024-06-30 $198
2024-03-31 $203
2023-12-31 $210
2023-09-30 $195
2023-06-30 $203
2023-03-31 $209
2022-12-31 $205
2022-09-30 $189
2022-06-30 $193
2022-03-31 $208
2021-12-31 $208
2021-09-30 $216
2021-06-30 $212
2021-03-31 $212
2020-12-31 $215
2020-09-30 $210
2020-06-30 $200
2020-03-31 $198
2019-12-31 $193
2019-09-30 $97
2019-06-30 $95
2019-03-31 $95
2018-12-31 $91
2018-09-30 $91
2018-06-30 $92
2018-03-31 $90
2017-12-31 $86
2017-09-30 $85
2017-06-30 $84
2017-03-31 $81
2016-12-31 $83
2016-09-30 $81
2016-06-30 $78
2016-03-31 $62
2015-12-31 $61
2015-09-30 $59
2015-06-30 $60
2015-03-31 $59
2014-12-31 $61
2014-09-30 $62
2014-06-30 $60
2014-03-31 $59
2013-12-31 $61
2013-09-30 $59
2013-06-30 $58
2013-03-31 $56
2012-12-31 $60
2012-09-30 $61
2012-06-30 $58
2012-03-31 $58
2011-12-31 $56
2011-09-30 $55
2011-06-30 $51
2011-03-31 $49
2010-12-31 $48
2010-09-30 $44
2010-06-30 $40
2010-03-31 $40
2009-12-31 $38
2009-09-30 $36
2009-06-30 $34
2009-03-31 $36
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $23.239B $2.950B
West Pharmaceutical Services Inc. is a leading global manufacturer with respect to design and production of technologically advanced, high-quality, integrated containment and delivery systems for injectable drugs and healthcare products. The Exton, PA-based company designs and produces these medical products in the Americas, Europe, the Middle East, Africa and the Asia Pacific. Its primary objective is to deliver quality products that cater to the exact product specifications and quality standards that customers expect and need. West Pharmaceutical operates through two segments: Proprietary Products and Contract-Manufactured Products.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $79.753B 21.76
Becton Dickinson (BDX) United States $65.165B 17.13
Cardinal Health (CAH) United States $29.869B 16.20
Labcorp (LH) United States $20.088B 16.66
Cooper (COO) United States $19.898B 28.32
Align Technology (ALGN) United States $17.037B 32.60
Henry Schein (HSIC) United States $9.198B 17.52
Merit Medical Systems (MMSI) United States $6.121B 31.26
DENTSPLY SIRONA (XRAY) United States $3.705B 10.08
CONMED (CNMD) United States $2.215B 18.48
Patterson (PDCO) United States $1.788B 9.43
STAAR Surgical (STAA) United States $1.312B 48.42
Lifevantage (LFVN) United States $0.165B 21.93
Pro-Dex (PDEX) United States $0.138B 27.49